Bernhard Mohr joined Evonik in 2012 to set up the Corporate Venturing activities of Evonik and became Managing Director of Evonik Venture Capital GmbH in 2013. He has more than 20 years of professional experience in the chemical and venture capital industry. Prior to joining Evonik, he was working for BASF where he held international positions in venture capital, strategic marketing, corporate development, controlling and research & development. He holds master degrees in chemistry from the Universities of Stuttgart and Cincinnati and earned his doctoral degree at the Max Planck Institute for Polymer Research in Mainz. Bernhard Mohr is active in various industry and board supervisory committees.
Evonik Venture Capital plans to invest €100 million in highly promising start-ups with breakthrough technologies and leading specialist venture capital funds. Collaborating with innovative start-up companies supplements Evonik’s approach of open innovation and creates excellent opportunities for accelerating the development of new businesses and opening up future growth fields. Since the inception of Evonik Venture Capital, the team reviewed more than 2.000 technology companies and completed investments in eleven start-up companies and seven funds.